Allos
Latest round
- Seed
Last raised
- Dec 2025
Total raised
- $5M
Investors
- 3
About Allos
Allos focuses on delivering AI solutions for pharmaceutical manufacturing.000 mn. Allos specializes in providing a comprehensive artificial intelligence platform tailored for pharmaceutical manufacturing, focusing on enhancing therapeutic success through innovative simulation technologies. The platform utilizes causal intelligence to model interventions and their outcomes before actual experiments, ensuring a well-defined operating window. Key offerings include simulation-led Design of Experiments (DoEs), robust scale-up methodologies, and data-driven tech transfer solutions, all aimed at minimizing risk and accelerating the drug development lifecycle. The company serves a diverse client base that includes pharmaceutical companies and biotechnology firms across North America and Europe, who rely on Allos's capabilities to achieve a higher probability of first-pass success in clinical trials.Allos generates revenue through a subscription-based model that facilitates ongoing access to its AI platform and services. Clients engage in long-term partnerships with the company, leveraging its advanced tools for various phases of drug development, including formulation development, scale-up, and tech transfer. This structured transaction framework allows clients to integrate Allos's offerings into their workflows, enhancing decision-making processes and reducing experimental failures. Specific pricing plans are designed to cater to the unique needs of each client, with distinct tiers reflecting the complexity of services utilized. By focusing on delivering high-value insights and operational efficiency, Allos secures its position within the competitive landscape of pharmaceutical manufacturing support services. Allos is targeting growth into new geographic regions and markets, focusing specifically on Europe and Asia by 2027. Additionally, Allos is currently designing new products aimed at improving AI-driven solutions for drug development, with anticipated launches expected in late 2026.
Who invested in Allos
3 investors across 1 round
See all investors in Allos
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Dec 29, 2025
Amount
$5M
Investors
Questions about Allos
Who invested in Allos?
Allos has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Allos raised?
Allos has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Allos last raise money?
Allos's most recent round on record is a Seed, in Dec 2025.
What does Allos do?
Allos focuses on delivering AI solutions for pharmaceutical manufacturing.
Where is Allos headquartered?
Allos is headquartered in Berkeley, US.
Which VCs invest in companies like Allos?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Allos's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Allos? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.